|
博士，主任医师，色情动漫 博导，南京医科大学硕士研究生导师，博士后合作导师。解放军东部战区总医院病理科主任。曾在美国印第安那大学病理系做访问学者。江苏省333高层次人才；六大人才高峰。主持国家自然科学基金3项，江苏省自然科学基金1项。获得国家发明专利授权9项，新申报发明专利5项。近年来其相关研究获得了较多研究成果，发表论文100余篇，其中第一作者或通讯作者SCI论文40余篇，多篇于著名的Oncogene、journal of pathology、Am J Surg Pathology、Modern Pathology、Histopathology等本学科国际著名杂志。多篇文章被2016版WHO泌尿及男生殖系统肿瘤分类引用。受邀参与编写2021年第五版WHO泌尿及男性生殖系统肿瘤分类。2012年获得刘志红院士青年医学奖。2013年荣获“吴秉铨病理学发展基金会”2013年度“优秀中青年学者奖”。2015《中华病理学杂志》编委会表彰授予“金笔奖”。2016.10“中国杰出青年病理医师奖”。2017江苏省医学新技术引进奖一等奖（第一完成人）；2018江苏省肿瘤医学二等奖（第一完成人）；2020江苏医学科技奖青年科技奖（第一完成人）。2020中国科协优秀论文；2020中华医学百篇论文。
1. Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J, Chen P, Xiang Z, Rao Q, Han X. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics. 2021 Jun 11;11(16):7640-76572. Xu MN, Rao Q. Excision Margin and Survival in Patients with High-Risk, Primary Cutaneous Melanoma: A Retrospective Study Based on Surveillance Epidemiology and End Result (SEER) Database. Dermatology. 2022;238(3):534-5413. Fang R, Wang X, Xia Q, Zhao M, Zhang H, Wang X, Ye S, Cheng K, Liang Y, Cheng Y, Gu Y, Rao Q. Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma. Oncogene. 2021 May;40(18):3303-33174. Pan R, Wang Z, Wang X, Fang R, Xia Q, Rao Q. CRTC1-SS18 Fusion Sarcoma With Aberrant Anaplastic Lymphoma Kinase Expression. International Journal of Surgical Pathology. 2022 Feb;30(1):99-1055. Liang Y, Fang R, Rao Q. An Insight into the Medicinal Chemistry Perspective of Macrocyclic Derivatives with Antitumor Activity: A Systematic Review. Molecules. 2022 Apr 29;27(9):28376. Fang R, Xia QY, Wang XT, Pan R, Ni H, Wang ZY, Rao Q. Frameshift mutation and inactivation of ARID1A in an epithelioid sarcoma. Pathology. 2022 Dec;54(7):938-9417. Xia QY, Wang XT, Zhao M, He HY, Fang R, Ye SB, Li R, Wang X, Zhang RS, Lu ZF, Ma HH, Wang ZY, Rao Q. TSC/MTOR -associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : A Targeted Next-generation Sequencing and Gene Expression Profiling Study. Am J Surg Pathol. 2022 Nov 1;46(11):1562-15768. Zhou Z, Huang D, Yang S, Liang J, Wang X, Rao Q. Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma. Pathol Oncol Res. 2022 Jul;28:16104799. Wang XT, Xia QY, Fang R, Zhang RS, Ye SB, Li R, Wang X, Lu ZF, Ma HH, Zhou XJ, He HY, Zhao M, Rao Q. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity. Hum Pathol. 2022 May;123:102–11210. Pan R, Wang X, Fang R, Xia Q, Wu N, Rao Q. Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study. Front Oncol. 2022 Nov 24;12:98005911. Xia QY, Wang XT, Zhao M, Rao Q. TSC/MTOR-associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum: Several Distinct Entities or a Tumor Family? Am J Surg Pathol. 2023;125(1)12. Wang X, Liu LL, Li Q, Xia QY, Li R, Ye SB, Zhang RS, Fang R, Chen H, Wu N, Rao Q. Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement. Histopathology. 2023;1–1213. Cheng K, Wang X, Bao W, Li R, Wang X, Rao Q. Urinary cytologic features of primitive neuroectodermal tumor primarily involving the kidney: A case report. Diagn Cytopathol. 2024 Jun;1–614. Wang XT, Fang R, He HY, Zhang W, Li Q, Sun SA, Wang X, Zhang RS, Teng XD, Zhou XJ, Xia QY, Zhao M, Rao Q. Recurrent Tuberous Sclerosis Complex/Mammalian Target of Rapamycin Mutations Define Primary Renal Hemangioblastoma as a Unique Entity Distinct From Its Central Nervous System Counterpart. Am J Surg Pathol. 2024;00:000–00015. Xu Y, Zhang X, Xia Q, Zhou Y, Wang X, Fang R, Wang Y, Tong Q, Chen J, Shi J, Fu Y, Rao Q. Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas: Further Support for a Close Morphologic Spectrum to Eosinophilic Solid and Cystic Renal Cell Carcinomas. Am J Surg Pathol. 2024;00:000–00016. Cheng K, Zhang X, Zhou X, Wang X, Bao W, Rao Q. Pitfalls in Urine Cytology: A Case of Fumarate Hydratase-Deficient Renal Cell Carcinoma Initially Diagnosed as High-Grade Urothelial Carcinoma. Diagn Cytopathol. 2024;1–617. Xia QY, Wang XT, Zhang HZ, Fu Y, Zhao M, Ye SB, Li R, Wang X, Zhang RS, Fang R, Rao Q. GPNMB Expression Identifies FLCN -Associated Eosinophilic Renal Tumors With Heterogeneous Clinicopathologic Spectrum and Gene Expression Profiles. Am J Surg Pathol. 2025 Nov 1;49(11):1158-1171.18. Ru, Fang; Xiaotong, Wang; Ruina, Wu; Rui, Pan; Miaomiao, Tian; Rusong, Zhang; Xue, Wei; Xuan, Wang; Shengbing, Ye; Feng, Li; Qiuyuan, Xia; Yang, Cheng; Qiu, Rao. SMARCA4/BRG1 deficiency induces a targetable dependence on oxidative phosphorylation in clear cell renal cell carcinoma..Carcinogenesis 2025 Jan 20;46(1).
|
